Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by DeSchuytner Brian, Chief Financial Officer. Officer active across 1 company, notably Mersana Therapeutics, Inc.. Cumulatively, 8 disclosures have been logged. History available since 14 January 2023. The latest transaction was filed on 15 January 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Brian DeSchuytner is the Chief Financial Officer at Mersana Therapeutics, Inc. In this role, he oversees all financial activities of the company, including financial planning and risk management. His financial expertise is crucial in guiding the financial strategy and supporting the growth of the firm.